These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 31647813)
1. Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model. Holohan DR; Van Gool F; Bluestone JA PLoS One; 2019; 14(10):e0217728. PubMed ID: 31647813 [TBL] [Abstract][Full Text] [Related]
2. Peripherally induced regulatory T cells contribute to the control of autoimmune diabetes in the NOD mouse model. Schuster C; Jonas F; Zhao F; Kissler S Eur J Immunol; 2018 Jul; 48(7):1211-1216. PubMed ID: 29604048 [TBL] [Abstract][Full Text] [Related]
3. Thymus-derived Foxp3 Yang J; Zou M; Pezoldt J; Zhou X; Huehn J J Mol Med (Berl); 2018 Dec; 96(12):1387-1394. PubMed ID: 30357435 [TBL] [Abstract][Full Text] [Related]
4. Differences in Expression Level of Helios and Neuropilin-1 Do Not Distinguish Thymus-Derived from Extrathymically-Induced CD4+Foxp3+ Regulatory T Cells. Szurek E; Cebula A; Wojciech L; Pietrzak M; Rempala G; Kisielow P; Ignatowicz L PLoS One; 2015; 10(10):e0141161. PubMed ID: 26495986 [TBL] [Abstract][Full Text] [Related]
5. High Thymic Output of Effector CD4 Zhao Y; Alard P; Kosiewicz MM J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853 [TBL] [Abstract][Full Text] [Related]
6. Thymus-Derived Regulatory T Cells Exhibit Moldenhauer LM; Schjenken JE; Hope CM; Green ES; Zhang B; Eldi P; Hayball JD; Barry SC; Robertson SA J Immunol; 2019 Aug; 203(3):647-657. PubMed ID: 31243091 [TBL] [Abstract][Full Text] [Related]
7. Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Yang BH; Hagemann S; Mamareli P; Lauer U; Hoffmann U; Beckstette M; Föhse L; Prinz I; Pezoldt J; Suerbaum S; Sparwasser T; Hamann A; Floess S; Huehn J; Lochner M Mucosal Immunol; 2016 Mar; 9(2):444-57. PubMed ID: 26307665 [TBL] [Abstract][Full Text] [Related]
8. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells. Bhaumik S; Mickael ME; Moran M; Spell M; Basu R J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282 [TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid hormone treatment enhances the cytokine production of regulatory T cells by upregulation of Foxp3 expression. Ugor E; Prenek L; Pap R; Berta G; Ernszt D; Najbauer J; Németh P; Boldizsár F; Berki T Immunobiology; 2018; 223(4-5):422-431. PubMed ID: 29223294 [TBL] [Abstract][Full Text] [Related]
10. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice. Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715 [TBL] [Abstract][Full Text] [Related]
11. Helios Thornton AM; Lu J; Korty PE; Kim YC; Martens C; Sun PD; Shevach EM Eur J Immunol; 2019 Mar; 49(3):398-412. PubMed ID: 30620397 [TBL] [Abstract][Full Text] [Related]
12. Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells and prevents the occurrence of diabetes in mice. Zheng Q; Xu Y; Liu Y; Zhang B; Li X; Guo F; Zhao Y J Mol Med (Berl); 2009 Dec; 87(12):1191-205. PubMed ID: 19841877 [TBL] [Abstract][Full Text] [Related]
13. Transient Depletion of Foxp3 Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K Front Immunol; 2021; 12():720133. PubMed ID: 34447385 [TBL] [Abstract][Full Text] [Related]
15. The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137 Foda BM; Ciecko AE; Serreze DV; Ridgway WM; Geurts AM; Chen YG J Immunol; 2020 Jun; 204(11):2887-2899. PubMed ID: 32295876 [TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. Brode S; Raine T; Zaccone P; Cooke A J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572 [TBL] [Abstract][Full Text] [Related]
17. Selective ablation of thymic and peripheral Foxp3 Yilmazer A; Zevla DM; Malmkvist R; Rodríguez CAB; Undurraga P; Kirgin E; Boernert M; Voehringer D; Kershaw O; Schlenner S; Kretschmer K Front Immunol; 2023; 14():1298938. PubMed ID: 38164128 [TBL] [Abstract][Full Text] [Related]
18. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Zheng Y; Josefowicz S; Chaudhry A; Peng XP; Forbush K; Rudensky AY Nature; 2010 Feb; 463(7282):808-12. PubMed ID: 20072126 [TBL] [Abstract][Full Text] [Related]
19. Increased CD4 Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423 [TBL] [Abstract][Full Text] [Related]
20. The nonconventional MHC class II molecule DM governs diabetes susceptibility in NOD mice. Morgan MA; Muller PS; Mould A; Newland SA; Nichols J; Robertson EJ; Cooke A; Bikoff EK PLoS One; 2013; 8(2):e56738. PubMed ID: 23418596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]